Inflammatory biomarkers and clinical domains of ageing in older adults with HIV
Background Older adults with HIV (OAWH) experience frailty and functional impairment despite optimal ART. Markers of persistent inflammation and immune activation have been linked to ageing-related outcomes in people with HIV, but their relationships with clinically relevant ageing-related domains remain incompletely characterised. We examined associations between inflammatory and immune-activation biomarkers and ageing-related clinical domains in a cohort of OAWH. Methods Subanalysis of the multicentre FUNCFRAIL cohort (NCT03558438). We measured circulating markers of inflammation and immune activation (sCD14, sCD163, FABP2/I-FABP, VCAM-1, hsCRP and IL-6), and, in a subset of participants, global DNA methylation in peripheral blood mononuclear cells. Frailty, physical performance and nutritional risk were assessed. Associations were analysed using correlation, Receiver Operating Characteristic (ROC) curves and multivariable regression. Results Participants were 23% women, with a median age 56 years, with long-standing HIV infection (median 21 years); 48% had ≥3 comorbidities and 8% were frail. In multivariable analyses, greater walking speed was independently associated with lower IL-6 levels (B=-0.531; p<0.01), while longer duration of known HIV infection was associated with higher IL-6 levels. Frailty was independently associated with higher CRP levels, and risk of malnutrition and COPD with higher sCD14 levels. VACS mortality risk remained independently associated with IL-6, VCAM-1, sCD163 and I-FABP. Global DNA methylation showed more limited associations, with serum albumin remaining independently associated in multivariable analysis. Conclusions Inflammatory and immune-activation biomarkers were associated with several clinically relevant ageing-related domains in OAWH. The most consistent finding across analytical approaches was the association between poorer physical function, particularly slower walking speed, and higher IL-6 levels. These findings support a link between persistent inflammatory burden and functional vulnerability in treated HIV and highlight the value of integrating biomarker research with objective measures of physical function in OAWH.
Authors
- Matilde Sánchez‐Conde (ORCID: https://orcid.org/0000-0003-3880-199X)
- Fátima Brañas (ORCID: https://orcid.org/0000-0001-7609-5382)
- Noemí Cabello
- Antonio Antela (ORCID: https://orcid.org/0000-0002-4819-0953)
- Miguel Torralba (ORCID: https://orcid.org/0000-0003-2166-7405)
- Margarita Ramírez (ORCID: https://orcid.org/0000-0002-4666-0114)
- Ma Jesús Bustinduy
- Pablo Ryan (ORCID: https://orcid.org/0000-0002-4212-7419)
- Mercedes Espiño (ORCID: https://orcid.org/0000-0002-1913-5664)
- Alfonso Cabello
- M. Luisa Montes
- I. Machuca
- M. José Galindo
Institutions
- Universidad Complutense de Madrid (ES)
- Universidade de Santiago de Compostela (ES)
- Hospital Universitario La Paz (ES)
- Instituto de Salud Carlos III (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Universitario de Guadalajara (ES)
- Hospital Clínico Universitario de Valencia (ES)
- Hospital Universitario Reina Sofía (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Donostiako Unibertsitate Ospitalea (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Hospital Universitario Infanta Leonor (ES)
- Centro de Investigación Biomédica en Red Enfermedades Infecciosas (ES)
- Instituto de Investigación Sanitaria Gregorio Marañón (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fimmu.2026.1991531
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00